RhythMedix® provides innovative technology to transform the medical monitoring industry and improve patient outcomes. The connected RhythmStar® System provides the first and only wearable multi-modality cardiac monitoring (Holter, Extended Wear Holter, Event and MCT) device that continuously and discreetly connects patients and clinicians via built-in 4G cellular technology for improved patient care. Powerful cloud-based algorithms evaluate every heartbeat and empower physicians with timely and actionable reporting that is verified by a RhythMedix US-based certified technician.
Employees: 51-200
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Pharos Cap... | pharosfund... |
Mentions in press and media 2
| Date | Title | Description |
| 08.01.2024 | Exclusive: Venrock ups its find size for the first time in a decade, raising $650M for tenth fund | It was mid-December as Venrock partner Bryan Roberts waltzed into one of the conference rooms of the venture capital firm he’s been running since 2007—his German Shepherd close at his heels with a tennis ball. When I asked how he’s been, he... |
| 18.02.2021 | RhythMedix Launches Next-Generation RhythmStar® Device, the First and Only Wearable Cardiac Monitor with Built-In Cellular Connectivity |